Security Stock News: TraceSafe (CSE: TSF) Joins Future Borders Coalition, Supports COVID-19 Recovery as a Leader in Tech Innovation Vancouver, British Columbia - April 12, 2021 (Newsfile Corp.) (Investorideas.com Newswire) Tracesafe Inc. (CSE: TSF) ("TraceSafe"), a global leader in wearable safety tech and connected workforce solutions |
AI Biometric Stock News: GBT (OTCPINK: GTCH) Filed a Nonprovisional patent for Systems and Methods of Facial and Body Recognition, identification and analysis SAN DIEGO - March 30, 2021 (Investorideas.com Newswire) GBT Technologies Inc. (OTCPINK: GTCH) ("GBT", or the "Company") with GBT Tokenize Corp. ("GBT/Tokenize") filed with U.S. Patent and Trademark Office ("USPTO") a nonprovisional patent for systems and methods of facial and body recognition identification and analysis. |
Biotech Stock News: Immunic, Inc. (NASDAQ: IMUX) Reports Year End 2020 Financial Results and Highlights Recent Activity NEW YORK - February 26, 2021 (Investorideas.com Newswire) Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, today announced financial results for the year ended December 31, 2020 and highlighted recent activity. |
Security Stock News: Zedcor Inc. (TSXV: ZDC) Signs 21-Month, $1.8 Million Agreement with a Construction Partnership to Provide Hybrid MobileyeZ Security Towers Calgary, Alberta - February 17, 2021 (Newsfile Corp.) (Investorideas.com Newswire) Zedcor Inc. (TSXV: ZDC) (the "Company" or "Zedcor"), a leading provider of strategic security solutions and remote video surveillance systems, is pleased to announce that it has entered into a rental and service agreement with a large engineering and construction joint venture (the "JV"). |
AI / Security Stock News: GBT (OTCPINK: GTCH) Filed Patent Application for AI Based Facial Recognition Security System SAN DIEGO - February 16, 2021 (Investorideas.com Newswire) GBT Technologies Inc. (OTCPINK: GTCH) ("GBT", or the "Company") with GBT Tokenize Corp. ("GBT/Tokenize") filed with U.S. Patent and Trademark Office ("USPTO") a patent for AI facial recognition system, for computers and mobile devices. |
Security Stock News: Plymouth Rock (CSE: PRT) (OTCQB: PLRTF) Accelerates Weapon Detection Radar to Assist United States Government Security Plymouth, Massachusetts - February 9, 2021 (Newsfile Corp.) (Investorideas.com Newswire) Plymouth Rock Technologies Inc. (CSE: PRT) (OTCQB: PLRTF) (FSE: 4XA) (WKN: A2N8RH) ("Plymouth Rock", "PRT", or the "Company") a leader in developing threat detection and unmanned technologies, is pleased to announce that its CODA-1(Cognitive Object Detection Apparatus) system has undergone further successful testing for detection of various concealed weaponry on a person at our PRT laboratories. |
HomelandDefenseStocks.com Q&A Interview with Scott Sacknoff, SPADE Defense Index ( $DXS) - Themes for Investors in 2021 Point Roberts, WA and Delta, BC - February 2, 2021 (Investorideas.com Newswire)Investorideas.com, a global news source and leading investor resource releases an exclusive Q&A interview through its defense portal HomelandDefenseStocks.com. |
Investor Ideas Podcast Corner - Chairman, CEO of Sigyn Therapeutics, Inc. (OTC:$SIGY) Discusses Treatment of Life-Threatening Conditions Induced by Cytokine Storm Syndrome Point Roberts, WA and Delta, BC - January 25, 2021 (Investorideas.com Newswire) Investorideas.com, a global news source and leading retail investor and trader resource issues a new CEO interview for the Podcast Corner. In today's special edition, Investor Ideas talks to Sigyn Therapeutics, Inc. (OTCMarkets: SIGY) Chairman and CEO, Jim Joyce. |
Boeing Aircraft Sales Plummet 59% in 2020, Lowest in Nearly 50 Years January 21, 2021 (Investorideas.com Newswire) The year 2020 was one of the worst years for Boeing’s aircraft sales. |
Biotech Stock News: Novavax (NASDAQ: NVAX) Finalizes Agreement with Commonwealth of Australia for 51 Million Doses of COVID-19 Vaccines Gaithersburg, Md. - January 8, 2021 (Investorideas.com Newswire) Novavax, Inc. (Nasdaq: NVAX), a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, today announced that it has executed an Advance Purchase Agreement with the Commonwealth of Australia for 51 million doses of NVX-CoV2373, Novavax' COVID-19 vaccine candidate. |